An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood Flow for Neonatology

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Feasibility trial on the use of a hybrid optical device integrating time-resolved near-infrared spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) for measurement of cerebral oxygen metabolism and blood flow in neonates.

The device wil be tested in four settings measuring:

1. Changes in cerebral oxygenation and haemodynamics after birth
2. precision and repeatability
3. The cerebral vaso-reactivity to arterial carbon dioxide
4. Assessment of the user-friendliness and loss of signal in routine care

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transitional Cerebrovascular Reactivity in Very Preterm Infants

NCT04423016

Cerebral Autoregulation Preterm Birth Premature Infant Disease

COMPLETED

Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database

NCT02863978

Infant, Premature

UNKNOWN NA

Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants

NCT01530360

Premature Infants Near-infrared Spectroscopy Oximetry

COMPLETED PHASE1

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

NCT04802629

Preterm Birth Oxygen Toxicity Fetal Hemoglobin

COMPLETED

Investigating Cerebral Oxygenation in the Newborn

NCT05588960

Hypoxic Ischemic Encephalopathy of Newborn Neonatal Encephalopathy Premature Infant Disease

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The BabyLux project aims to provide a precise, accurate, and robust device to continuously monitor cerebral oxygen metabolism and blood flow in critically ill newborn infants. This will be achieved by combining time resolved near-infrared spectroscopy (TRS) with newly developed diffuse correlation spectroscopy (DCS) in a single device. The innovative aspects of the project are related to the use of advanced solutions, based on state-of-the-art photonic components, which have already been tested in laboratory and clinical tests on adults.

Time Resolved Near-infrared spectroscopy and Diffuse Correlation Spectroscopy

The proposed solution will integrate two advanced photonic techniques, TRS and DCS. Both techniques rely on the use of an optical fibre probe (sensor) to illuminate with very low power near-infrared light the scalp and to collect the diffusively reflected optical signal that has propagated through the scalp and skull, and therefore carries information on the deeper cortical region. The different absorption spectra of oxygenated and deoxygenated haemoglobin in the near-infrared range allows for the non-invasive monitoring of the two species in the cortical tissue.

TRS and DCS prototypes are available and have been technically tested in laboratory settings and successfully validated during preclinical trials on adult volunteers and patients.

Measured TRS/DCS parameters

TRS measures the attenuation and the temporal broadening of relatively short light pulses (pulse duration \~100 ps) through a diffusive medium (e.g. a neonate's head). TRS has the ability to resolve path-lengths (or equivalently time-of-flights) of photons that have propagated through the tissues. This enables TRS to separate the absorption and scattering coefficients allowing for absolute measurements, and to utilize time-gating of path-lengths to emphasize signals from deeper tissues. This is particularly important for separating intra- and extra-cerebral signals for brain monitoring.

DCS relies on the fact that temporal correlation of light fields in turbid media also obeys a diffusion equation, albeit a slightly different one than is used for TRS. Thus DCS shares the light penetration advantages of TRS, but, since DCS explicitly measures red blood cell movement, it provides a direct measure of quantities such as cerebral blood flow (CBF).

The specific combination of DCS and TRS allows for the assessment of cerebral oxygen metabolism and CBF in a complete (i.e. CBF and oxygenation are simultaneously and independently provided), accurate (i.e. based on absolute measurements of optical parameters) and robust (i.e. potentially less affected by artefacts related to superficial systemic activity or sensor/head movements) way.

The aim of this study is to perform clinical measurements using the BabyLux instrument in different clinical real-life settings to validate this new technology in terms of feasibility, repeatability of measurements, and user friendliness in neonatal medicine.

The BabyLux system is tested in four different real-life settings to measure:

1. The increase in oxygenation and change in blood flow during the minutes after birth to specify the expected range of measurement;
2. The precision and repeatability of measurements by reapplying the NIRS sensor several times on slightly different sites of the head in a relatively steady condition;
3. The cerebral vaso-reactivity to arterial carbon dioxide tension in mechanically ventilated newborns to monitor induced changes in cerebral blood flow;
4. The user-friendliness and loss of signal in routine care situations (e.g. during 24-hour monitoring of neonates undergoing intensive care).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodynamic Instability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

* GA \> 37 weeks
* planned to be delivered by an uncomplicated elective caesarean section

* GA \< 37 weeks
* Postnatal age more \> 24 hours
* Mechanically ventilated
* Clinically stable
* Normal brain ultrasound
* Transcutaneous pCO2 monitoring (tcpCO2)

* Postnatal age \< 28 days
* ventilatory support by mechanical ventilation or nasal CPAP

Exclusion Criteria

* need for resuscitation or supplementary oxygen during the first 10 minutes following umbilical cord clamping
* congenital malformations

Setting 3:

* Congenital malformations

Setting 4:

* Congenital malformations

Maximum Eligible Age

4 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No